Reverse biological engineering of hrdB to enhance the production of avermectins in an industrial strain of Streptomyces avermitilis
Open Access
- 7 June 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 107 (25), 11250-11254
- https://doi.org/10.1073/pnas.1006085107
Abstract
Avermectin and its analogues are produced by the actinomycete Streptomyces avermitilis and are widely used in the field of animal health, agriculture, and human health. Here we have adopted a practical approach to successfully improve avermectin production in an industrial overproducer. Transcriptional levels of the wild-type strain and industrial overproducer in production cultures were monitored using microarray analysis. The avermectin biosynthetic genes, especially the pathway-specific regulatory gene, aveR, were up-regulated in the high-producing strain. The upstream promoter region of aveR was predicted and proved to be directly recognized by σhrdB in vitro. A mutant library of hrdB gene was constructed by error-prone PCR and selected by high-throughput screening. As a result of evolved hrdB expressed in the modified avermectin high-producing strain, 6.38 g/L of avermectin B1a was produced with over 50% yield improvement, in which the transcription level of aveR was significantly increased. The relevant residues were identified to center in the conserved regions. Engineering of the hrdB gene can not only elicit the overexpression of aveR but also allows for simultaneous transcription of many other genes. The results indicate that manipulating the key genes revealed by reverse engineering can effectively improve the yield of the target metabolites, providing a route to optimize production in these complex regulatory systems.Keywords
This publication has 43 references indexed in Scilit:
- Medium optimization for the production of avermectin B1a by Streptomyces avermitilis 14-12A using response surface methodologyBioresource Technology, 2009
- A high‐throughput screen for hyaluronic acid accumulation in recombinant Escherichia coli transformed by libraries of engineered sigma factorsBiotechnology & Bioengineering, 2008
- Isolation of soluble proteins from an industrial strain Streptomyces avermitilis in complex culture medium for two-dimensional gel electrophoresisJournal of Microbiological Methods, 2008
- SIGffRid: A tool to search for sigma factor binding sites in bacterial genomes using comparative approach and biologically driven statisticsBMC Bioinformatics, 2008
- Interspecies DNA Microarray Analysis Identifies WblA as a Pleiotropic Down-Regulator of Antibiotic Biosynthesis in StreptomycesJournal of Bacteriology, 2007
- Systems biology of antibiotic production by microorganismsNatural Product Reports, 2007
- Complete genome sequence and comparative analysis of the industrial microorganism Streptomyces avermitilisNature Biotechnology, 2003
- The novel Streptomyces olivaceoviridis ABC transporter Ngc mediates uptake of N-acetylglucosamine and N,N'-diacetylchitobioseMolecular Genetics and Genomics, 2002
- Domain 1.1 of the σ70 Subunit of Escherichia coli RNA Polymerase Modulates the Formation of Stable Polymerase/Promoter ComplexesJournal of Molecular Biology, 2001
- Region 1 of σ70 is required for efficient isomerization and initiation of transcription by Escherichia coli RNA polymeraseJournal of Molecular Biology, 1997